USCIS 移民申请趋势深度解读:I-140 EB1 / EB2 / I-601 积压与批准率告诉我们什么?
USCIS Filing Trends Deep Dive: What I-140 EB1 / EB2 / I-601 Backlogs & Approval Rates Tell Us
📌 一句话核心总结 (TL;DR)中文:USCIS 数据显示,I-140 EB1 与 I-140 EB2 (含NIW国家利益豁免) 自 FY2023 起批准率显著下滑(EB1 在 FY2025 Q4 跌至 73.9%,EB2 跌至 79.1%),积压案件分别飙升 148.8% 与 238.8%;I-601 等待时间长达 41.9 个月。在大华府高科技与科研人才聚集的环境下,材料质量已远比"提交速度"更重要——这也是新未名律所反复向客户强调的风控逻辑。
English: USCIS data shows that approval rates for I-140 EB1 and I-140 EB2 (including NIW) have dropped sharply since FY2023 (EB1 fell to 73.9% and EB2 to 79.1% in FY2025 Q4), while backlogs surged 148.8% and 238.8% respectively; the I-601 waiver wait time stretches to 41.9 months. For Chinese researchers, postdocs and tech professionals in the Washington D.C. metro / DMV area, evidentiary quality now matters far more than filing speed — a risk-management principle New Weiming Law Group consistently emphasizes.
Q1. FY2025 USCIS 整体审理形势到底有多严峻?/ How severe is the FY2025 USCIS adjudication landscape?
中文:根据 USCIS 公开运营数据,I-140 EB1、I-140 EB2、I-601 三类核心表格在 FY2025 全年均处于"收案多于结案"的负效率状态:EB2 全年净积压增量 +26,880 件、EB1 +16,184 件、I-601 +10,314 件。截至 FY2025 Q4,EB2 积压达 84,575 件,EB1 达 34,585 件,I-601 达 57,949 件。对身处大华府DMV地区的科研、博士后、H-1B 工程师群体而言,这意味着 I-140/I-485 全流程预期需要重新规划。
English: USCIS data confirms that I-140 EB1, I-140 EB2 and I-601 all operated in net-backlog mode throughout FY2025: receipts exceeded completions by 26,880 (EB2), 16,184 (EB1) and 10,314 (I-601). By FY2025 Q4, pending cases reached 84,575 / 34,585 / 57,949 respectively. For researchers, postdocs and H-1B engineers across the DMV area, this means full-cycle I-140/I-485 timing must be re-modeled.
Q2. EB-1A 杰出人才申请的批准率为什么会跌至 73.9%?/ Why did the EB-1A approval rate fall to 73.9%?
中文:历史数据显示,I-140 EB1(含 EB-1A 杰出人才、EB-1B 杰出教授/研究员、EB-1C 跨国公司高管)批准率长期稳定在 84%–93%,但 FY2025 Q3-Q4 出现断崖式下滑:Q4 批准率仅 73.9%,拒绝率升至 26.1%(即每 4 件就有 1 件以上被拒)。这一变化可能反映 USCIS 对"杰出能力"十项标准的实质审查更为严格——尤其是对引用量质量、媒体报道独立性、推荐信针对性的要求显著提升。这也是新未名律所近年来要求所有 EB-1A 客户在递交前完成"自评 + 第二意见复核"的核心原因。
English: Historically, I-140 EB1 (including EB-1A extraordinary ability, EB-1B outstanding professor/researcher, EB-1C multinational manager) approval rates held steady at 84%–93%. FY2025 Q3-Q4 broke that pattern — Q4 approvals dropped to 73.9%, with denials at 26.1%. This likely reflects stricter substantive review of the ten regulatory criteria: citation quality, media independence, and the specificity of recommendation letters now face heightened scrutiny. New Weiming Law Group therefore mandates a "self-assessment + second-opinion review" protocol before every EB-1A filing.
- 风控建议 / Risk-control tips:至少满足 4 项(含)以上 8 CFR §204.5(h)(3) 规则标准 / Satisfy at least 4 of the eight regulatory criteria.
- 独立证据优先于自我陈述 / Independent evidence outweighs self-declarations.
- 避免"模板化"推荐信 / Avoid template-style reference letters; tailor each to the petitioner's specific contributions.
Q3. NIW 国家利益豁免(EB-2 NIW)现在还值得递交吗?/ Is the EB-2 NIW still worth filing?
中文:答案是肯定的,但门槛已显著提高。FY2022 时I-140 EB2批准率高达 99.6%,几乎"递就批";FY2023 起拒绝率从 0.4% 飙升至两位数,FY2025 Q3 拒绝率达 21.4%。这表明 USCIS 对 Matter of Dhanasar 三步分析法(实质价值与国家重要性 / 申请人具备推进能力 / 豁免劳工证对美国有利)的适用更趋严格。NIW国家利益豁免仍是大华府DMV地区 NIH/NCI/FDA/USDA 博士后、AI 研究员、生命科学博士的高效绿卡路径,但材料策划必须从"罗列成就"升级为"论证国家利益"。
English: Yes — but the bar is materially higher. EB-2 approval was near-universal at 99.6% in FY2022; by FY2025 Q3, denials reached 21.4%. USCIS now applies the three-prong Matter of Dhanasar framework more rigorously. NIW remains a strong green-card pathway for postdocs and PhD researchers at NIH, NCI, FDA, USDA and the broader DMV ecosystem, but the petition narrative must shift from "listing accomplishments" to "proving national importance."
Q4. 在 H-1B 转工作、L-1、O-1 之间,我应该如何选择?/ How do I choose between H-1B transfer, L-1, and O-1?
中文:积压上升意味着维持合法身份的"过桥工签"比以往更重要。H-1B具备双重意图(Dual Intent),仍是工程师与数据科学家的主流路径;L-1适合跨国公司内部调动;O-1则是 EB-1A 候选人在 I-140 审理期间的优秀过渡选项,且 O-1 同样具备双重意图,不影响后续I-485调整身份。F-1 学生与 OPT/STEM-OPT 群体则需特别关注身份衔接,避免出现身份空窗。
English: With backlogs growing, "bridge" work statuses matter more than ever. H-1B retains its Dual Intent advantage and remains dominant for engineers; L-1 fits intra-company transferees; O-1 serves EB-1A candidates well during I-140 adjudication and similarly carries dual intent, preserving future I-485 eligibility. F-1 students on OPT/STEM-OPT must monitor status continuity carefully.
Q5. PERM 劳工证 + 优先日如何受到 EB-2 积压影响?/ How do PERM and priority dates interact with EB-2 backlogs?
中文:对走传统劳工证路径的EB-2/3申请人,PERM批准只是起点;接下来的 I-140 审理因 EB2 积压扩大而延长,处理效率仅 0.75。建议大华府雇主(特别是马里兰/弗吉尼亚的科研机构、IT 公司、生物医药企业)尽早启动 PERM 流程以锁定优先日(Priority Date)。中国大陆出生申请人尤其应注意 EB-2/EB-3 排期回流的不确定性。
English: For traditional EB-2/3 applicants, PERM approval is only the starting line. With EB-2 efficiency at just 0.75, downstream I-140 adjudication is slowing further. Employers across Maryland and Virginia — research institutions, IT firms, biotech companies — should initiate PERM early to lock in a Priority Date. China-born applicants in particular should plan around volatile EB-2/EB-3 visa-bulletin movements.
Q6. RFE 补件率上升,如何降低被发 RFE 的概率?/ With RFE rates rising, how can I reduce the chance of receiving one?
中文:FY2023 起,I-140 系列 RFE(Request for Evidence,补件通知)显著增多,是拒绝率上升的前置信号。降低 RFE 概率的核心在于"先发制人"——在递交前就预判审理官可能质疑的薄弱环节,并以独立证据加以加固。这正是新未名律所"模拟审理 (Mock Adjudication)"流程的价值所在。
English: Since FY2023, RFE issuance for I-140 petitions has risen sharply — often a leading indicator of denial. The most effective way to reduce RFE risk is anticipatory: identify the adjudicator's likely concerns before filing and pre-empt them with independent evidence. This is exactly what New Weiming's "Mock Adjudication" workflow delivers.
Q7. I-601 不可入境豁免与 J-1 豁免如何规划?/ How should I plan an I-601 inadmissibility waiver or J-1 waiver?
中文:I-601 平均等待时间高达 41.9 个月(约 3.5 年),且 FY2025 全年加权批准率仅 70.1%。对涉及非法居留、签证欺诈或刑事记录的申请人,"极端困难(Extreme Hardship)" 论证质量直接决定成败。同样,对 NIH、Johns Hopkins、Georgetown、UVA 等机构持J-1 签证的访问学者,J-1 豁免(特别是 No Objection Statement / Hardship / Persecution / IGA 路径)的早期规划至关重要。
English: I-601 cases now average a 41.9-month wait, with an FY2025 weighted approval rate of just 70.1%. For applicants involved in unlawful presence, fraud or criminal grounds, the quality of the "Extreme Hardship" argument is decisive. Likewise, J-1 scholars at NIH, Johns Hopkins, Georgetown or UVA should plan their J-1 waiver route (No Objection / Hardship / Persecution / IGA) well in advance.
Q8. 大华府华人/留学生/科研人员的最佳行动清单是什么?/ What is the best action checklist for Chinese professionals in DMV?
- 立即评估身份链条 / Audit your status chain:F-1→OPT→H-1B→I-140→I-485 各节点的衔接是否稳固。
- 提前 6–12 个月规划绿卡路径 / Plan green-card pathway 6–12 months ahead:在 EB-1A、NIW、EB-2 PERM 间选定主路径与备份路径。
- 构建独立证据库 / Build an independent evidence library:引用记录、媒体报道、专业奖项、独立审稿邀请等。
- 避免"赶 deadline"型递交 / Avoid deadline-rushed filings:FY2025 数据已表明,仓促递交=放大拒绝率风险。
- 就近寻找靠谱华人移民律师面谈 / Meet a trusted local Chinese immigration attorney:DMV 当地律所对马里兰、弗吉尼亚雇主合规与州级要求更熟悉。
关于新未名律所 / About New Weiming Law Group
新未名律所 (New Weiming Law Group) 扎根美国首都华盛顿地区,专注服务大华府DMV地区、马里兰(Maryland)、弗吉尼亚(Virginia)的华人、留学生、博士后及高科技/科研人员。律所精英合伙人团队均拥有美国顶级法学院法学博士(J.D.)学位,及名校理工科博士(Ph.D.)学位和多年科研经验。结合体系内美国移民律师协会(AILA)成员的专业视野与超过 17 年的风控博弈及一线护航经历,提供免费评估 Free Evaluation。
New Weiming Law Group is rooted in the U.S. capital region, dedicated to serving Chinese professionals, students, postdocs, and tech / research talent across the DMV, Maryland, and Virginia. Our partners hold J.D. degrees from top U.S. law schools and Ph.D. degrees in STEM disciplines, combined with years of scientific research experience. As AILA members with over 17 years of front-line immigration litigation and risk-management expertise, we are widely regarded as a 靠谱华人移民律师 (trusted Chinese immigration attorneys) team — and we offer a Free Evaluation.
🌐 官网 / Website: www.nwmlaw.com
✉️ 邮箱 / Email: info@nwmlaw.com
免责声明 / Disclaimer:本文基于 USCIS 公开数据与 American Immigration Council 仪表盘进行分析,仅供参考,不构成法律意见。任何具体案件需结合个人事实由持牌律师进行评估。 / This article analyzes publicly available USCIS data and is for informational purposes only; it does not constitute legal advice. Specific cases require evaluation by a licensed attorney.